Lv11
60 积分 2025-07-28 加入
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
3个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
4个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
4个月前
已完结
Combinatorial strategies to target RAS-driven cancers
4个月前
已完结
Intermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group
1年前
已完结
miR-19a-mediated downregulation of RhoB inhibits the dephosphorylation of AKT1 and induces osteosarcoma cell metastasis
1年前
已完结
皖公网安备34019202002308
